A. Limbic system
B. Emetic system
C. Chemoreceptor trigger zone (CTZ)
D. Opioid receptors in G.I.T
A. Diphenhydramine
B. Atropine
C. Naloxane
D. Nalorphine
A. Aspirin
B. Ibuprufen
C. Diclofenac potassium
D. Mefenamic acid
E. Both A & B
A. Respiratory alkalosis
B. Haemorrhage
C. Hepatic necrosis
D. Gastric Ulceration
A. Reye’s syndrome
B. Nausea
C. Diarrhoea
D. Acid-base imbalance
A. Analgesia is associated with μ and k receptors
B. Dysphoria is associated with S receptors
C. NSAIDS benefit by preventing prostaglandin synthesis
D. Naloxane is a non-competitive antagonist and irreversibly opposes the opioids
A. Remifentanil
B. Morphine
C. Sufentanil
D. Fentanyl
A. Naloxone
B. Nalosphine
C. Nalpuphine
D. Methadine
A. It inhibits thromboxanes
B. It stimulates Prostacyclins
C. It is a vasodilator
D. Ithelps in reducing inflammatory aggregate
A. Vitamin K
B. Barbiturates
C. Acetominophen
D. Acetyl salicylic acid
